Xiaohong Liu
Jinan Military Region
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Xiaohong Liu.
World Journal of Gastroenterology | 2015
Ming Geng; Xuan Xin; Li-Quan Bi; Luting Zhou; Xiaohong Liu
Many factors are considered to contribute to hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC), including products of HBV, HBV integration and mutation, and host susceptibility. HBV X protein (HBx) can interfere with several signaling pathways associated with cell proliferation and invasion, and HBx C-terminal truncation has been suggested to impact the development of HCC. This review focuses on the pathological functions of HBx in HBV-induced hepatocarcinogenesis. As a transactivator, HBx can affect regulatory non-coding RNAs (ncRNAs), including microRNAs and long ncRNAs. HBx is also involved in epigenetic modification and DNA repair. HBx interacts with various signal-transduction pathways, such as the p53, Wnt, and nuclear factor-κB pathways. We conclude that HBx hastens the development of hepatoma.
Hepatitis Monthly | 2013
Xiaoyan Lin; Qiangxiu Wang; Zhixin Cao; Ming Geng; Yongcheng Cao; Xiaohong Liu
Background Epidemiological evidence has clearly indicated that chronic infection with the hepatitis B virus (HBV) is the major risk factor for developing hepatocellular carcinoma (HCC). Nonetheless, the mechanisms by which HBV contributes to the pathogenesis of HCC have not been fully elucidated. Objectives Our aim was to characterize differential gene expression profiles related to the Wnt signaling pathway between primary tumor and adjacent normal tissues in HCC patients with concomitant HBVinfection . Materials and Methods An oligoGEArray® (an oligonucleotide-based gene expression array platform) containing 126 Wnt signaling pathway-related genes was used to compare gene expressions between primary HCC and adjacent non-tumorous liver tissues from 10 patients with HCC. Selected differential genes were identified with real-time RT-PCR and immunohistochemistry (IHC). In particular, the protein of the differential gene DVL3 (disheveled, dsh homolog 3 [Drosophila]) was chosen to investigate whether it is up regulated in primary tumor correlated with the clinic pathological characteristics of HCC patients. For this purpose we examined 56 HCC tissue samples via IHC for the presence of DVL3 protein. Results Sixteen genes were identified with significant differential expression between HCC and adjacent non-tumorous liver tissue. These genes have been previously associated with the Frizzled signaling pathway, cell cycle, transcription, or protein degradation. All (100%) of the tumor samples results from 56 HCC patients tested were positive for DVL3 via IHC. Based on the intensity of DVL3 immunoreactivity, 25 (44.6%) and 31 (55.4%) of the patients were classified aslow and high-DVL3, respectively, which correlated with tumor stage (P = 0.029). Conclusions This study clarified a number of Wnt pathway-related genes which are dysregulated in HBV-associated HCC. These genes may be contributedto the frequent activation of the Wnt signaling pathway. Our results promote the role of the Wnt signaling pathway in HBV-associated HCC.
Cell Transplantation | 2016
Xiaojing Lin; Tingbao Zhao; Melissa J. Walker; Aishi Ding; Shide Lin; Yongcheng Cao; Jinfeng Zheng; Xiaohong Liu; Ming Geng; Xiao Ming Xu; Shaojun Liu
Spinal cord injury (SCI) is a significant clinical challenge, and to date no effective treatment is available. Oligodendrocyte progenitor cell (OPC) transplantation has been a promising strategy for SCI repair. However, the poor posttransplantation survival and deficiency in differentiation into myelinating oligodendrocytes (OLs) are two major challenges that limit the use of OPCs as donor cells. Here we report the generation of an OL lineage population [i.e., pro-oligodendroblasts (proOLs)] that is relatively more mature than OPCs for transplantation after SCI. We found that proOLs responded to lipopolysaccharide (LPS)-stimulated microglia conditioned medium (L+M) by preserving toll-like receptor 4 (TLR4) expression, improving cell viability, and enhancing the expression of a myelinating OL marker myelin basic protein (MBP), compared to other OL lineage cells exposed to either LPS-stimulated (L+M) or nonstimulated microglia conditioned medium (L-M). When L+M-stimulated proOLs were intrathecally delivered through a lumbar puncture after a T10 thoracic contusive SCI, they promoted behavioral recovery, as assessed by the Basso–Beattie–Bresnahan (BBB) locomotor rating scale, stride length, and slips on the grid tests. Histologically, transplantation of L+M proOLs caused a considerable increase in intralesional axon numbers and myelination, and less accumulation of invading macrophages when compared with the vehicle control or OPC transplantation. Thus, transplantation of proOLs, preconditioned by L+M, may offer a better therapeutic potential for SCI than OPCs since the former may have initiated the differentiation process toward OLs prior to transplantation.
World Journal of Gastroenterology | 2012
Ming Geng; Yongcheng Cao; Yingjian Chen; Hui Jiang; Li-Quan Bi; Xiaohong Liu
International Journal of Clinical and Experimental Pathology | 2014
Peifeng Li; Yongcheng Cao; Luting Zhou; Xiaohong Liu; Ming Geng
International Journal of Clinical and Experimental Pathology | 2014
Li-Quan Bi; Xiaohong Liu; Cuicui Wang; Yongcheng Cao; Ruiqi Mao; Peifeng Li; Ming Geng
International Journal of Clinical and Experimental Pathology | 2015
Ming Geng; Luting Zhou; Xiaohong Liu; Peifeng Li
Publisher | 2016
Xiaojing Lin; Tingbao Zhao; Melissa J. Walker; Aishi Ding; Shide Lin; Yongcheng Cao; Jinfeng Zheng; Xiaohong Liu; Ming Geng; Xiao-Ming Xu; Shaojun Liu
Molecular Medicine Reports | 2016
Yanhua Wu; Yingjian Chen; Qing Li; Yanwen Gong; Xiaohong Liu; Liquan Bi; Chengjin Hu
Archive | 2014
Peifeng Li; Yongcheng Cao; Luting Zhou; Xiaohong Liu; Ming Geng